Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment

被引:0
|
作者
Merola, Joseph F. [1 ]
Chiou, Albert S. [2 ]
During, Emmanuel [2 ]
Costanzo, Antonio [3 ]
Foley, Peter [4 ]
Ardeleanu, Marius [5 ]
Wu, Jiangming [6 ]
Ozturk, Zafer E. [7 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[2] Stanford Univ, Palo Alto, CA USA
[3] Humanitas Univ, Milan, Italy
[4] Skin Hlth Inst, Carlton, Vic, Australia
[5] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[6] Sanofi, Bridgewater, NJ USA
[7] Sanofi, Cambridge, MA USA
关键词
patient-reported outcomes; sleep; depression; anxiety; moderate-to-severe;
D O I
10.1093/bjd/ljac140.029
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
335
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Dupilumab provides long-term improvement in pruritus in children with severe atopic dermatitis and adolescents and adults with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Praestgaard, Amy
    Zhang, Haixin
    Wang, Zhixiao
    Rossi, Ana B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 79 - 79
  • [22] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
    Parker, Jennifer J.
    Sugarman, Jeffrey L.
    Silverberg, Nanette B.
    Gonzalez, Mercedes Elena
    Ramien, Michele L.
    Teng, Joyce M. C.
    Paller, Amy S.
    PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
  • [23] Dupilumab treatment induces rapid clinical improvement of itch in patients with moderate-to-severe atopic dermatitis
    Silverberg, Jonathan I.
    Eckert, Laurent
    Ardeleanu, Marius
    Chen, Zhen
    Akinlade, Bolanle
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozi, Gianluca
    Gadkari, Abhijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB113 - AB113
  • [24] Treatment satisfaction in patients receiving dupilumab for moderate-to-severe atopic dermatitis
    Lans, A.
    Van der Schaft, J.
    Bakker, D.
    Ariens, L.
    Thijs, J. H.
    De Bruin-Weller, M. S.
    Balak, D. M. W.
    ALLERGY, 2019, 74 : 82 - 82
  • [25] Impact on health-related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate-to-severe atopic dermatitis
    Miniotti, Marco
    Lazzarin, Giulia
    Ortoncelli, Michela
    Mastorino, Luca
    Ribero, Simone
    Leombruni, Paolo
    DERMATOLOGIC THERAPY, 2022, 35 (05)
  • [26] Dupilumab significantly improves sleep disturbance in adults with moderate-to-severe atopic dermatitis: Results of the DUPISTAD study
    Merola, Joseph F.
    Chiou, Albert S.
    During, Emmanuel
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB46 - AB46
  • [27] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Chao, J.
    Eckert, L.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Plaum, S.
    Graham, N.
    Pirozzi, G.
    Gadkari, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
  • [28] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [29] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [30] PATIENT PERCEPTION OF TREATMENT WITH LONG-TERM DUPILUMAB MONOTHERAPY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Simpson, E.
    Lacour, J.
    Beck, L.
    Zhang, H.
    Aamodt, K.
    Rossi, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S55 - S56